Agents That Target Androgen Synthesis in Castration-Resistant Prostate Cancer-Reference-Cited by-同舟云学术

Agents That Target Androgen Synthesis in Castration-Resistant Prostate Cancer

Published:2013-01 Issue:1 Volume:19 Page:34-42
ISSN:1528-9117
Container-title:The Cancer Journal
language:en
Short-container-title:

Author:

Ferraldeschi Roberta,de Bono Johann

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference55 articles.

1. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate.;Huggins;Cancer Res,1941

2. . A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.;Crawford;N Engl J Med,1989

3. . Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.;Eisenberger;N Engl J Med,1998

4. . Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.;Tannock;N Engl J Med,2004

5. . Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.;Petrylak;N Engl J Med,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors;Cells;2022-09-07

2. Prospective computational design and in vitro bio-analytical tests of new chemical entities as potential selective CYP17A1 lyase inhibitors;Bioorganic Chemistry;2020-01

3. Human cytochrome P450 enzymes 5–51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition – toxic effects and benefits;Drug Metabolism Reviews;2018-07-03

4. WOMEN IN CANCER THEMATIC REVIEW: New roles for nuclear receptors in prostate cancer;Endocrine-Related Cancer;2016-11

5. Oxazolinyl derivatives of [17(20)E]-21-norpregnene differing in the structure of A and B rings. Facile synthesis and inhibition of CYP17A1 catalytic activity;Steroids;2016-11